News

GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. GW Pharmaceuticals announced positive top-line results from an exploratory Phase 2 placebo-controlled clinical study of a...

Intarcia Therapeutics, Inc. announced that the U.S. FDA has accepted for active review its NDA for ITCA 650, an investigational therapy for the treatment of type 2 diabetes (T2D).  Intarcia looks forward to working closely with...

Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools. Clinerion’s Patient Recruitment System (PRS) Patient Finder tool has a wealth of health data...

Kraig Biocraft Laboratories , the leading developer of spider silk based fibers announced it had secured a long term property lease in Texas for the Company’s domestic mulberry production. Over the next 60 days the Company...

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced a leadership change in North America. William (Bill) Valle (56) has been appointed the new Chief Executive Officer (CEO) of North America,...

Alexion Pharmaceuticals Inc announced that the U.S. FDA has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting anti-C5 antibody that inhibits terminal complement, which is being evaluated for the treatment of patients with paroxysmal nocturnal hemoglobinuria...

Hologic, Inc announced that the U.S. FDA has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant assay is a nucleic acid amplification test for the quantitative detection of RNA from HIV in...